Non-small cell lung cancer invading the chest wall

Area of Science:

• Thoracic surgery
• Surgical oncology
• Pulmonology

Background:

• Non-Small cell lung cancer (NSCLC) invading the chest wall signifies an advanced disease stage.
• Chest wall resection is feasible in most patients, with reconstruction needed in 40-64% of cases.
• Surgical resection of NSCLC with chest wall invasion has become technically manageable, yielding good outcomes.

Purpose of the Study:

• To highlight the current challenges in managing advanced Non-Small cell lung cancer with chest wall invasion.
• To emphasize the importance of complete resection and lymph node control for patient survival.
• To discuss the role of multimodal therapy in improving outcomes for resectable NSCLC.

Main Methods:

• Review of surgical techniques for chest wall resection and reconstruction in advanced NSCLC.
• Analysis of factors influencing survival, including resection completeness and lymph node status.
• Discussion of the integration of non-surgical modalities like chemotherapy and radiation therapy.

Main Results:

• Chest wall resection and en bloc lung resection are technically achievable with good results.
• Incomplete resection and mediastinal lymph node involvement significantly compromise survival rates.
• The primary challenges now lie in optimizing neoadjuvant/adjuvant therapies and reducing recurrence.

Conclusions:

• Surgical resection for NSCLC invading the chest wall is a viable option.
• Complete tumor removal and effective management of lymphatic spread are paramount for improved survival.
• Integrating chemotherapy and radiation therapy is essential to enhance resectability and decrease recurrence rates.